212results about How to "Improve curing rate" patented technology

A method and compositions are described for labeling a targeting agent with Ga-68, in which eluate from an acid-eluted Ge-68/Ga-68 generator is combined with a macrocycle-containing targetable agent. The labeling method and compositions disclosed ensure that a simple elution of gallium-68, taken directly from a generator, can be used without further manipulation to quantitatively label a macrocycle-containing targetable agent. The Ga-68 labeled targeting agent so produced is useful with specific targeting agents, and is most especially useful in a pretargeting method for positron emission tomographic detection.

The invention discloses a normal-temperature preparation method for ultrafine lung-regulating and cough-relieving powder. The method comprises the following steps of: selecting bulk pharmaceutical decoction pieces of lily, dwarf lilyturf root, rhizoma pinelliae preparata, aster, liquoric root, thinleaf milkwort root-bark, common anemarrhena, coastal glehnia root, dried orange peel, indian buead and floatstone; smashing bulk pharmaceuticals into coarse powder at the normal temperature; uniformly mixing the obtained coarse powder according to a certain proportion, putting into a rod mill for smashing, conveying into a special bilateral airflow sieving machine through wind for sieving with a 500-mesh sieve, sieving to obtain powder of which the particle diameter is less than or equal to 25 micrometers, conveying the powder which is obtained by sieving to a cyclone aggregator through airflow generated by a draught fan for collecting to obtain finished ultrafine lung-regulating and cough-relieving powder; and collecting powder which is not sieved with the 500-mesh sieve, and conveying to the rod mill through a pipeline for smashing circularly once again. The method has the advantages that: the entire preparation process is performed at the normal temperature; the particle diameter of a prepared finished medicament is less than or equal to 25 micrometers, and the cell-wall breaking rate and the biological availability are greatly increased; and due to the adoption of the bilateral airflow sieving machine, the preparation process of the ultrafine lung-regulating and cough-relieving powder is simplified.

The invention discloses a compound type sludge fuel, which comprises the following raw materials in percentage by weight: 20-50% of dry sludge, 20-50% of coal dust, 10-20% of residual oil, 5-10% of clay and 4-10% of biomass. The invention also discloses a preparation method of the compound type sludge fuel. Compared with a single dry sludge formed solid, the compound type sludge fuel increases the heat value by 1 time, and is easier to burn; and the curing rate is increased by 5-10%.

The invention provides a method for extracting rhenium from rhenium-rich concentrates. The method comprises the following steps of: mixing the rhenium-rich concentrates with quick lime, grinding a mixture, feeding oxygen-enriched air into the mixture, and roasting the mixture at a temperature of 400-900 DEG C; sizing and immersing the roasted mixture by using water, and filtering after the immersion is finished; adding an impurity removing agent into the filtered liquid so as to remove calcium and trace heavy metal ions; filtering after removing impurities; and carrying out ion exchange process on the filtered liquid, which is subjected to impurity removal and filtering, through anion exchange resin, obtaining ammonium rhenate solution after desorption, and obtaining ammonium perrhenate through reconcentration and crystallization. According to the method provided by the invention, quick lime oxygen-enriched roasting and water immersion are used, so that the operations of decoppering, arsenic removal and desulfuration are carried out, therefore rhenium, arsenic and sulfur are oxidized sufficiently under the oxygen enrichment condition; the rhenium, arsenic and sulfur are combined with calcium oxide, so that insoluble substances are generated; the effects of removing copper, arsenic and sulfur are more thorough in the water immersion condition, and the disadvantage that the calcium content is high in the quick lime roasting and water immersion technology is solved through using the impurity removing agent to remove impurities; and the recovery rate of rhenium is high, so that the method provided by the invention is favorable to industrialized application.

The invention relates to the field of harmless fly ash treating, and provides a method and system for treating fly ash in a manner combining mechanochemistry and washing, with characteristics of high efficiency, low cost and zero harm. The system comprises a feed bin, a horizontal roller type ball mill, a stirring kettle and a plate-and-frame filter press, wherein the bottom of the feed bin is connected to a feed opening of the horizontal roller type ball mill; stainless steel milling balls are placed in a closed barrel body of the horizontal roller type ball mill; two ends of a discharge pipeline are connected to the bottom of the horizontal roller type ball mill and the upper part of the stirring kettle respectively; the upper part of the stirring kettle is connected with a water inlet pipeline, and the bottom of the stirring kettle is connected to the plate-and-frame filter press. According to the method and the system which are disclosed by the invention, the heavy metal solidification, the dioxin degradation and the chlorine removal of the fly ash can be realized at the same time in high efficiency, the treated fly ash is thoroughly harmless and has conditions of resource utilization, and the heavy metal solidification rate of the treated fly ash is more than 70%; an additive is not additionally added, so that the treating cost is low; the technological process is simple, the reaction conditions are mild, the treating process is environment friendly, and harmful by-products are not generated; the equipment investing cost and the operating cost are low, the treating effects are significant, and the technological process is simple to realize.

The invention features a polymerizable composition that comprises a free-radically polymerizable acidic resin, and a photoinitiator system comprising a polycyclic aromatic component. The photoinitiator system may also contain a visible light sensitizer, an iodonium salt, and a tertiary amine.

The present invention refers to a method of treating a cancerous or non-cancerous skin lesion of a subject, e.g. a human patient, by epidermal radioisotope therapy, a specialized type of brachytherapy, comprising the steps of (a) defining and marking an area of skin to be treated; (b) covering said area with a protective layer, e.g. a protective film or foil; (c) applying a tailor-made radioactive source by applying a layer of a radioactive source material on said protective layer, such that said area is covered by said material while any area not to be treated is spared; and (d) removing the radioactive source after a predetermined time period of irradiation.

The invention discloses a method for detecting miRNAs based on a liquid chip of HCR and particularly relates to the method for detecting the target miRNAa content in to-be-detected RNA. The method comprises the following steps: (A): (1) respectively designing and synthesizing a probe M, a probe 1 and a probe 2 corresponding to one or more target miRNAs; (2) carrying out HCR reaction on the probe M corresponding to the target miRNA, microspheres corresponding to the target miRNA, the probe 1 and the probe 2, so as to obtain an HCR reactant; and (3) carrying out fluorescent mark detection, determining whether the HCR reactant contains one or more target miRNAs according to the existence of a fluorescence signal in the HCR reactant. The method has the beneficial effects that the sensitivity of a traditional liquid chip is greatly improved, and meanwhile, the aspects of the quantitative range, the specificity and the accuracy degree well presented, so it can be foreseen that a detection measure is provided for the establishment of a relatively rapid, sensitive and simple miRNAs liquid chip detection system for the early-stage new tumor markers.

The invention provides an arsenious waste curing method. The arsenious waste curing method comprises the following steps of: (1) grinding arsenious waste into powder, adding into iron, boron and phosphorous basic glass ingredients and a stabilizer, and uniformly mixing raw materials and drying; and (2) placing the dried raw materials into a stainless steel mould, heating to 400-500 DEG C at a constant speed within 0.8-1.2 hours, and insulating for 1-2 hours, wherein intensity of pressure in the stainless steel mould is maintained to be 10-12Mpa all the time in the heating process; and founding, homogenizing, then carrying out natural cooling to room temperature, taking out the mould, and demoulding, thus the solid arsenic crystal product is obtained. The invention also provides a solid arsenic crystal product generated by the arsenious waste curing method. Arsenic curing rate of the arsenious waste curing method is high, and the produced cured product can be used for making a building or decorative material.

The present invention discloses a Chinese medicine for curing hyperlipemia, characterized in that the medicine is made from the following crude drugs with the weight portions: 8 to 10 portions of cassia twig, 8 to 10 portions of pachyma cocos, 7 to 9 portions of red peony root, 7 to 9 portions of moutan bark, 7 to 9 portions of peach kernel, 7 to 9 portions of barley sprout, 8 to 10 portions of Chinese yam, 7 to 9 portions of hawkthorn, 8 to 10 portions of rehmannia root, 8 to 10 portions of figwort root, 8 to 10 portions of dwarf lilyturf, 7 to 9 portions of dried orange peel, 7 to 9 portions of flagleaf, 5 to 7 portions of liquorice and 5 to 7 portions of lotus leaf. The present invention takes ''activating blood and dissolving stasis, reinforcing spleen and clearing dampness, nourishing yin and producing body fluid'' as the curing principle, and has obvious curing effect on hyperlipemia.

The present invention relates to a method of determining P-glycoprotein expression and/or function for a patient with solid tumors, leukemias, and other malignancies. The invention also relates to using a P-glycoprotein expression and/or function diagnostic in conjunction with methods for treating solid tumors, leukemias, and other malignancies with a chemotherapeutic agent in combination with zosuquidar. The methods are particularly effective in treating acute myelogenous leukemia, metastatic breast cancer, and other cancers expressing P-glycoprotein, wherein the P-glycoprotein expression and/or function is used to select a treatment option for the patient.

The invention relates to an industrial waste disposal technology, in particular to a method of using a cement kiln intermediate product for harmless disposal of electrolytic manganese slag. High-temperature airflow is produced in a production process of a cement kiln and has the advantages of a large capacity, high temperature, long residence time, an oxidizing atmosphere and the like; high-alkaline material is an alkaline material which is about to enter the kiln in the production process of cement and has high CaO content and high activity. According to the method, the high-temperature airflow and high-alkaline material are creatively used for the harmless disposal of environmentally harmful elements and components such as residual acid, soluble manganese and ammonia nitrogen in the electrolytic manganese slag to control and reduce a harmful effect of the electrolytic manganese slag on the atmosphere, water, soil and other environments and the occupational health of employees duringdownstream application. After the harmless disposal, the electrolytic manganese slag can be widely used in the fields of cement bifunctional materials, wall materials, road surface materials, concrete aggregates and the like.

The invention provides quantum dot ink and quantum dot membrane and a production method thereof. The quantum dot ink comprises 2wt%-4.5wt% of quantum dots, 70wt%-90wt% of (meth)acrylic acid monomer, 5wt%-15wt% of photoinitiator, 0-10wt% of acrylate oligomer and 0.1wt%-5wt% of assistant; and the particle size of the quantum dots is 6-9 nm or 2-5 nm. The quantum dots of the quantum dot ink have goodcompatibility with a light-cured resin system, and a curing effect of light-cured resin is good. The quantum dot membrane is produced by printing the quantum dot ink on transparent resin membrane through an ink-jet printing technology and conducting curing and shaping on the transparent resin membrane, and the technology is simple.

A combination preparation for remedying the gastroesophageal reflux disease (GERD) and the functional dyspepsia is characterized in that the prescription of the combination preparation consists of a proton pump depressor and a gastrointestinal power drug of itopride; the proton pump depressor is selected from one of a Pantoprazole, a Omeprazole, a Esomeprazole, a Lansoprazole, a Rabeprazole, a Tenatoprazole and a Leminorazole, wherein the Pantoprazole is preferential, and at the same time the neutral form of the basic salt of the proton pump depressor is also included, such as Na^plus, Mg^2plus, Ca^2plus, K^plus or Li ^plus salt and a pure optical stereoisomer of the proton pump depressor or an active metabolite of the proton pump depressor; the gastrointestinal power drug is the itopride and a ramification of the itopride or one of the medicinal salts of the itopride; in the combination preparation, the weight ratio of the Pantoprazole and the itopride is 2 to 5 to 2 to 7. The invention has important affect for remedying the gastroesophageal reflux disease and the functional dyspepsia, and the preparation method of the invention is simple and convenient; the cost is low; the invention is fit for being orally taken by the patient; the invention has good conformance performance, high curative effect, low recrudescence rate and little adverse reaction.

The invention relates to an innocent treatment method for arsenic containing mixed salt. The method comprises the following steps of: (1) uniformly mixing arsenic containing mixed salt and slag or/and cullet, and controlling the content of arsenic in the mixed material at1.0-4.8wt% to obtain a mixed material; (2) feeding the mixed material into a furnace, heating to 1150-1250 DEG C, and insulating and melting for 0.4-2.4 hours to obtain melt; and (3) pouring the melt to a die to prepare solid or entering into water for water-quenching while the melt is still hot to obtain particle arsenic containing solid. The method for treating the arsenic containing mixed salt is free from environmental hidden danger, and free from secondary pollution, and the whole process is simple in flow, short in processing time, simple and convenient to operate, low in energy consumption, and suitable for industrialized production.

The invention provides a pharmaceutical composition for treating femoral head necrosis and a preparation method thereof. The pharmaceutical composition disclosed by the invention comprises the following components in parts by weight: 1-5 parts of pseudo-ginseng, 5-20 parts of herba epimedii, 1-10 parts of carthamus tinctorius, 5-30 parts of the root of red-rooted salvia, 5-20 parts of drynaria rhizome, 5-20 parts of teasel root, 1-15 parts of corydalis tuber, and 1-15 parts of the root of bidentate achyranthes. The traditional Chinese medicine granules disclosed by the invention have the characteristics of definite curative effect, stable quality and the like, is convenient to carry and take, have the functions of invigorating the circulation of blood, dispersing blood stasis, tonifying kidneys and reinforcing bones, and are used for treating gore blockage, deficiency of kidneys and bone erosion; symptoms include pain of hip bone, especially at night, inhibited bending and stretching, and soreness and weakness of waist and knees; and the above symptoms appear in the early stage and the middle stage of femoral head necrosis.

The invention relates to a Chinese medicament composition for treating infectious bursal disease. The Chinese medicament composition comprises the following components in parts by weight: 1 to 10 parts of indigowoad root, 1 to 10 parts of astragalus, 1 to 6 parts of epimedium herb, 1 to 6 parts of liquorice root and 1 to 6 parts of Mongolian dandelion herb. The Chinese medicament composition is reasonable and scientific in formula composition, can clear away heat and toxic materials, strengthen the body resistance to eliminate pathogenic factors, astringe intestines, stop dysentery, improve the immunity, resist viruses and refresh the brain, does not have toxic and side effects or medicament residues, is convenient to use, lower in cost and high in kill ratio of bacteria, viral pathogens and microorganisms, and does not have drug resistance.

The present invention relates to a method and composition for the use of a neoadjuvant to be used in with existing therapies to break host immune tolerance to tumor cells or other types of diseased cells. More precisely the present invention is directed to a vaccine which delivers a polypeptide adjuvant such as HSP72, or a cytokine molecule such as GMCSF, which is encoded in a polynucleotide that will be expressed at high levels within tumor cells and may also bind to tumor cell antigens. The vaccine may be administered alone, or in conjunction with a known tumor antigen or vaccine. After a period of time sufficient for expression of the polynucleotide and for the binding of adjuvant to cancer antigens, the cancer will be treated with conventional therapies, allowing the adjuvant/antigen complex to be released to the interstitial fluids where they will be accessible to antigen presenting cells of the host immune system. The presentation of the cancer antigen complexed with adjuvant as well as cytokine stimulation of the host immune system will cause the host to mount a heightened immune response against all remaining cancer cells or tumors which share these antigens.